Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
about
MEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsImprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegalyLandscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone releaseThe pathogenesis of pituitary tumours.Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegalyRegulation of growth hormone secretion by (pro)renin receptor.Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenomaMechanisms of disease: The pathogenesis of pituitary tumors.Oncogenesis and mutagenesis of pituitary tumors.Pathology of the human pituitary adenomasModulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells.The role of genetic and epigenetic changes in pituitary tumorigenesis.G alpha 13-mediated transformation and apoptosis are permissively dependent on basal ERK activity.Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response.Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas.Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations.The curious case of Gαs gain-of-function in neoplasia.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureAdenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
P2860
Q28088746-2A8996AC-ABB1-452F-A698-8D654ABF1710Q28360510-AB63AEBB-FAFB-4574-A65D-76FD06205395Q30370834-410A26B5-9A16-490A-9A2A-B75C83861E92Q30445060-872E1CFE-A53E-44C8-B056-EE2942D7B8B7Q30449260-B1D5E704-1E43-482A-B33D-C4BCDAF666D7Q34988259-90C94A77-69C4-4DEC-9BC2-604FD41162CBQ35228807-71015FC9-30FE-41E6-B42F-24B17940E980Q35679184-63984F7D-0CE6-4F8E-B9E8-1DB49D08513FQ35763542-FD24AE89-1B68-4090-B0C8-219E1B4EDB13Q35972238-266A8D0E-D1EC-4EB1-9D4E-F09B9DC1C108Q36576996-C081E0E6-213F-482A-AF38-C43A40EB1AC5Q36605354-DB6031C2-C483-4817-95E3-A419F9C27994Q36848906-2C796E37-15C8-4EC1-A428-E35FF9A450A5Q37202220-7D8F3787-7EC4-45A1-BD29-694140AF0A6EQ37574629-CFA9D30F-AC89-4772-BB91-FCA62F83D56EQ38274982-5A68C242-8DD4-41A1-9E07-18FCFDFEB0B1Q40649357-BF07A429-D64D-44AA-88A7-E37F8DA4BA12Q42488346-09525A15-CF22-40FD-A36C-0FA729BE009FQ46306529-2CE9BA7D-A247-4DE3-BA13-B86700280DFEQ53773272-F2D5813F-DCE6-4585-B7C5-3C44936F2EA1Q54497289-30220A7B-AD97-444D-854C-3961ED0F4F94Q54955004-0F138313-0229-4157-A985-863F8A261AE0Q57144951-7FD330AD-64D6-42C7-BD7D-0F63E503D965Q58897830-B46BA6C8-5F38-492D-BF61-9929672647CF
P2860
Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Clinical characteristics of ac ...... ors contain mutant Gs protein.
@en
type
label
Clinical characteristics of ac ...... ors contain mutant Gs protein.
@en
prefLabel
Clinical characteristics of ac ...... ors contain mutant Gs protein.
@en
P2093
P356
P1476
Clinical characteristics of ac ...... ors contain mutant Gs protein.
@en
P2093
P304
P356
10.1210/JCEM-71-6-1416
P407
P577
1990-12-01T00:00:00Z